Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA)Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseNot yet recruitingPhase 22025-04-23NCT06931704

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Nantes University Hospital223

36 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Léon BerardLyonFrance11
CH Bretagne AtlantiqueVannesFrance5
CH Cornouaille QuimperQuimperFrance1
CH Côte BasqueBayonneFrance2
CH de LibourneLibourneFrance2
CH de SAINT NAZAIRESaint-NazaireFrance2
CH Le Mans - Centre de cancérologie de la SartheLe MansFrance1
CH PérigueuxPérigueuxFrance3
CH Saint-JeanPerpignanFrance1
CH Tarbes-LourdesTarbesFrance1
CHD VendéeLa Roche-sur-YonFrance41
CHRU - Hôpital du Haut LévêquePessacFrance1
Chru BretonneauToursFrance8
CHRU DijonDijonFrance2
CHRU NancyNancyFrance31
CHU AngersAngersFrance87
CHU BesançonBesançonFrance32
CHU CaenCaenFrance48
CHU Clermont- Ferrand - Hôpital ESTAINGClermont-FerrandFrance1
CHU de Nice - Hôpital l'Archet 1NiceFrance2
CHU de Nîmes - Institut de Cancérologie du GardNîmesFrance1
CHU de PoitiersPoitiersFrance40
CHU LimogesLimogesFrance42
CHU NantesNantesFrance86
CHU ToulouseToulouseFrance76